CN Patent

CN115477679A — 用于治疗丙型肝炎病毒的核苷酸半硫酸盐

Assigned to Atea Pharmaceuticals Inc · Expires 2022-12-16 · 3y expired

What this patent protects

下述结构的半硫酸盐，其用于治疗丙型肝炎感染的宿主；以及药物组合物和剂型，包括其固体剂型。

USPTO Abstract

下述结构的半硫酸盐，其用于治疗丙型肝炎感染的宿主；以及药物组合物和剂型，包括其固体剂型。

Drugs covered by this patent

Patent Metadata

Patent number: CN115477679A
Jurisdiction: CN
Classification: —
Expires: 2022-12-16
Drug substance claim: No
Drug product claim: No
Assignee: Atea Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.